Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Comment

Avinash Dinmohamed; O Visser; RH Verhoeven; MWJ Louwman; FH van Nederveen; SM Willems; MAW Merkx; Valery Lemmens; ID Nagtegaal; S Siesling

doi:10.1016/s1470-2045(20)30265-5

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Comment

Avinash Dinmohamed
, O Visser
, RH Verhoeven
, MWJ Louwman
, FH van Nederveen
, SM Willems
, MAW Merkx
, Valery Lemmens
, ID Nagtegaal
, S Siesling

Public Health

Research output: Contribution to journal › Article › Academic › peer-review

491 Citations (Scopus)

Original language	English
Pages (from-to)	750-751
Number of pages	2
Journal	Lancet Oncology
Volume	21
Issue number	6
DOIs	https://doi.org/10.1016/s1470-2045(20)30265-5
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC NIHES-02-65-02

Access to Document

10.1016/s1470-2045(20)30265-5

http://hdl.handle.net/1765/130243

Cite this

@article{8dd6e7f1e84e40598a42609c376dd662,

title = "Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Comment",

author = "Avinash Dinmohamed and O Visser and RH Verhoeven and MWJ Louwman and \{van Nederveen\}, FH and SM Willems and MAW Merkx and Valery Lemmens and ID Nagtegaal and S Siesling",

year = "2020",

doi = "10.1016/s1470-2045(20)30265-5",

language = "English",

volume = "21",

pages = "750--751",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "6",

}

TY - JOUR

T1 - Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Comment

AU - Dinmohamed, Avinash

AU - Visser, O

AU - Verhoeven, RH

AU - Louwman, MWJ

AU - van Nederveen, FH

AU - Willems, SM

AU - Merkx, MAW

AU - Lemmens, Valery

AU - Nagtegaal, ID

AU - Siesling, S

PY - 2020

Y1 - 2020

U2 - 10.1016/s1470-2045(20)30265-5

DO - 10.1016/s1470-2045(20)30265-5

M3 - Article

SN - 1470-2045

VL - 21

SP - 750

EP - 751

JO - Lancet Oncology

JF - Lancet Oncology

IS - 6

ER -